MedPath

河北恒利集团制药股份有限公司

Ownership
-
Established
2001-08-08
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

88

NMPA:88

Drug Approvals

生脉饮(党参方)

Approval Number
国药准字Z13021553
Approval Date
Oct 13, 2020
NMPA

山菊降压片

Approval Number
国药准字Z20073244
Approval Date
Oct 13, 2020
NMPA

Albumin Tannate Tablets

Product Name
鞣酸蛋白片
Approval Number
国药准字H13022628
Approval Date
Oct 13, 2020
NMPA

Erythromycin Estolate Granules

Product Name
依托红霉素颗粒
Approval Number
国药准字H13020192
Approval Date
Oct 13, 2020
NMPA

Vitamin B6 Tablets

Product Name
维生素B6片
Approval Number
国药准字H13021964
Approval Date
Oct 13, 2020
NMPA

Vitamin B1 Tablets

Product Name
维生素B1片
Approval Number
国药准字H13021954
Approval Date
Oct 13, 2020
NMPA

Sulfogaiacol,Pentoxyverine and Promethazine Granules

Product Name
愈酚喷托异丙嗪颗粒
Approval Number
国药准字H13023388
Approval Date
Oct 13, 2020
NMPA

三黄片

Approval Number
国药准字Z13021780
Approval Date
Oct 13, 2020
NMPA

五味子颗粒

Approval Number
国药准字Z13021781
Approval Date
Oct 13, 2020
NMPA

Berberine Hydrochloride Tablets

Product Name
盐酸小檗碱片
Approval Number
国药准字H20053476
Approval Date
Oct 13, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 9
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.